Want to see AU:NGS full AI Analyst Report?
Top Page
Nutritional Growth Solutions Ltd.
(Sydney:NGS)
Select Model
Select Model
Rating:39Underperform
Price Target:
AU$0.02
▲(20.00% Upside)
Action:Downgraded
Date:08/11/26
The score is primarily held down by weak financial performance—declining revenue, sharply compressed gross margin, persistent large losses, and ongoing operating cash burn—despite the positive shift back to positive equity in 2025. Technicals are largely flat (price aligned with major moving averages) with slightly negative momentum signals, offering limited near-term support. Valuation is also constrained by losses (negative P/E) and no dividend yield data.
Positive Factors
Equity Recovery
The return to positive equity improves solvency relative to prior years and provides a limited capital base for continuing operations, although the cushion remains small and vulnerable while losses and cash outflows persist.
Negative Factors
Persistent Revenue Decline
A multi-year contraction in revenue signals weakening demand, distribution, or competitive positioning. Without renewed sales growth, fixed costs become harder to absorb and the company’s path to sustainable profitability remains constrained.
Read all positive and negative factors
Positive Factors
Negative Factors
Equity Recovery
The return to positive equity improves solvency relative to prior years and provides a limited capital base for continuing operations, although the cushion remains small and vulnerable while losses and cash outflows persist.
Read all positive factors
Nutritional Growth Solutions Ltd. (NGS) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$6.99M
Dividend YieldN/A
Average Volume (3M)896.54K
Price to Earnings (P/E)―
Beta (1Y)-0.70
Revenue Growth-33.05%
EPS Growth94.22%
CountryAU
Employees6
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-1.07
Shares Outstanding487,313,200
10 Day Avg. Volume39,734
30 Day Avg. Volume896,540
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.10
Price to Sales (P/S)0.01
P/FCF Ratio-0.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nutritional Growth Solutions Ltd. Business Overview & Revenue Model
Company Description
Headquartered in Tel Aviv, Israel, Nutritional Growth Solutions Ltd. is an enterprise focused on developing, producing, and marketing protein supplements specifically tailored for pediatric use. These products reach consumers both domestically and...
Nutritional Growth Solutions Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
30
Negative
Cash Flow
12
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.68M | 2.48M | 3.06M | 2.95M | 3.04M |
| Gross Profit | 263.89K | 811.00K | 842.00K | 1.44M | 1.36M |
| EBITDA | -1.66M | -2.45M | -3.01M | -4.32M | -4.71M |
| Net Income | -1.77M | -2.54M | -2.89M | -4.25M | -4.78M |
Balance Sheet | |||||
| Total Assets | 1.79M | 709.00K | 936.00K | 3.03M | 3.44M |
| Cash, Cash Equivalents and Short-Term Investments | 517.35K | 31.00K | 172.00K | 1.52M | 3.00M |
| Total Debt | 504.34K | 162.00K | 362.00K | 37.00K | 73.00K |
| Total Liabilities | 1.55M | 1.37M | 1.11M | 954.00K | 626.97K |
| Stockholders Equity | 240.16K | -658.00K | -177.00K | 2.08M | 2.81M |
Cash Flow | |||||
| Free Cash Flow | -1.03M | -1.93M | -2.35M | -6.98M | -3.74M |
| Operating Cash Flow | -1.25M | -1.93M | -2.35M | -6.97M | -3.69M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | -4.00K | -63.06K |
| Financing Cash Flow | 1.77M | 1.78M | 998.00K | 2.21M | 3.42M |
Nutritional Growth Solutions Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | AU$261.18M | 23.09 | 56.29% | ― | 160.87% | 188.14% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | AU$33.25M | -0.51 | 13.40% | 1.21% | 8.82% | 55.22% | |
48 Neutral | AU$89.41M | -19.23 | -11.08% | ― | 9.08% | -183.87% | |
46 Neutral | AU$13.33M | -1.79 | -88.51% | ― | 11.96% | -81.99% | |
43 Neutral | AU$13.39M | -4.47 | -12.90% | ― | 0.46% | 46.48% | |
39 Underperform | AU$6.99M | -0.01 | 226.76% | ― | -33.05% | 94.22% |
* Consumer Defensive Sector Average
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
<0.01
16.67%
AU:NOU
Noumi Limited
0.12
-0.04
-25.00%
AU:AHF
Australian Dairy Nutritionals Group
0.02
-0.03
-61.36%
AU:BLS
Bioxyne Limited
1.14
0.68
147.83%
AU:BUB
Bubs Australia Ltd.
0.10
-0.06
-37.50%
AU:NUC
Nuchev Pty Ltd
0.09
-0.06
-43.33%
Nutritional Growth Solutions Ltd. Corporate Events
Nutritional Growth Solutions Shareholders Back Board and Sprout Acquisition Plans
Aug 10, 2026
Shareholders of Nutritional Growth Solutions approved all resolutions at the company’s Annual General Meeting, including the election of directors Manik Pujara, Andrew Grover and Selasi Berdie by strong majorities. The voting results reinfor...
Nutritional Growth Solutions Cuts Cash Outflows and Moves on Sprout Organic Deal
Jul 31, 2026
Nutritional Growth Solutions reported a quarter of significantly improved operating performance, with net operating cash outflows more than halved to US$195,000 and customer receipts of US$338,000, supported by deliberate inventory investment and ...
Nutritional Growth Solutions Plans New Share and Option Placement
Jul 21, 2026
Nutritional Growth Solutions Ltd., an ASX-listed company in the nutrition industry trading under the code NGS, is active in capital markets through the issuance of ordinary shares and options. The company uses placements and other structured offer...
Balmain Resources Exits Substantial Holding in Nutritional Growth Solutions
Jun 5, 2026
Balmain Resources Pty Ltd has ceased to be a substantial holder in Nutritional Growth Solutions Ltd., after selling 1,169,101 ordinary shares on market. The disposal, completed on 25 May 2026 for proceeds of $31,876.58, reduces Balmain’s vot...
Nutritional Growth Solutions Reports Departure of Director Without Equity Interests
Jun 2, 2026
Nutritional Growth Solutions Limited has notified the ASX that director Rachel Hirsh has ceased to be a director of the company as of 31 May 2026. The filing confirms that Hirsh held no relevant interests in the company’s securities or contr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.